Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
FIVE9
FIVN
$2.08B
| $17.5M | 0.01% |
266,900
-278,900
| -51% | -$17.1M |
|
1077
AMERISAFE
AMSF
$562M
| $17.4M | 0.01% |
263,893
+800
| +0.3% | +$53K |
|
|
CGC
1078
Canopy Growth
CGC
$376M
| $17.4M | 0.01% |
82,770
+31,680
| +62% | +$6.29M |
|
1079
Tompkins Financial
TMP
$1.42B
| $17.4M | 0.01% |
189,892
-25,930
| -12% | -$2.24M |
|
1080
Voyager Therapeutics
VYGR
$181M
| $17.4M | 0.01% |
1,245,501
+172,600
| +16% | +$2.51M |
|
1081
Pebblebrook Hotel Trust
PEB
$2.18B
| $17.4M | 0.01% |
647,595
+378,695
| +141% | +$9.98M |
|
1082
FTI Consulting
FCN
$5.14B
| $17.4M | 0.01% |
156,800
+14,000
| +10% | +$1.53M |
|
|
PFNX
1083
DELISTED
Pfenex Inc.
PFNX
| $17.3M | 0.01% |
1,579,805
+56,000
| +4% | +$556K |
|
|
HCCI
1084
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $17.3M | 0.01% |
551,300
+133
| +0% | +$3.81K |
|
|
SAND
1085
DELISTED
Sandstorm Gold
SAND
| $17.3M | 0.01% |
2,317,610
+33,910
| +1% | +$221K |
|
1086
Hanmi Financial
HAFC
$935M
| $17.2M | 0.01% |
862,657
-46,100
| -5% | -$890K |
|
|
RARX
1087
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $17.2M | 0.01% |
+366,845
| New | +$16.2M |
|
1088
S&P Global
SPGI
$124B
| $17.2M | 0.01% |
+62,900
| New | +$16.3M |
|
1089
Macerich
MAC
$7.4B
| $17.2M | 0.01% |
637,419
+332,269
| +109% | +$9.13M |
|
1090
CytomX Therapeutics
CTMX
$690M
| $17.1M | 0.01% |
2,063,271
+530,971
| +35% | +$3.58M |
|
1091
BioMarin Pharmaceuticals
BMRN
$11.9B
| $17.1M | 0.01% |
202,471
-353,600
| -64% | -$26.7M |
|
1092
J.M. Smucker
SJM
$13.5B
| $17.1M | 0.01% |
164,403
-164,077
| -50% | -$17.4M |
|
|
CLR
1093
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $17.1M | 0.01% |
498,300
-195,500
| -28% | -$6.07M |
|
1094
Orthofix Medical
OFIX
$492M
| $17.1M | 0.01% |
369,269
-48,421
| -12% | -$2.28M |
|
1095
Western New England Bancorp
WNEB
$259M
| $17M | 0.01% |
1,768,089
+27,462
| +2% | +$265K |
|
|
THR
1096
DELISTED
Thermon Group Holdings
THR
| $17M | 0.01% |
633,900
-10,200
| -2% | -$257K |
|
|
SPNS
1097
DELISTED
Sapiens International
SPNS
| $16.9M | 0.01% |
736,900
+96,500
| +15% | +$2.09M |
|
1098
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.7B
| $16.8M | 0.01% |
268,400
+197,800
| +280% | +$12M |
|
|
HABT
1099
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $16.8M | 0.01% |
1,613,700
-22,800
| -1% | -$227K |
|
|
FLG
1100
Flagstar Bank National Association
FLG
$5.87B
| $16.8M | 0.01% |
466,708
-766,767
| -62% | -$28.3M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.